Skip to the content
Active Campaigns
Membership
DONATE
logo mainlogo darklogo light
  • HOME
  • ABOUT
    • ABOUT
    • NAAMA PRESIDENT
      • NAAMA PRESIDENT
      • PRESIDENT’S LETTERS
        • PRESIDENT’S LETTERS 2026
        • PRESIDENT’S LETTERS 2025
        • PRESIDENT’S LETTERS 2024
        • PRESIDENT’S LETTERS 2023
    • GOVERNING BOARDS
      • BOARD OF DIRECTORS
      • EXECUTIVE COMMITTEE
    • COMMITTEES
      • NAAMA Committees
    • BYLAWS
  • FOUNDATION
    • BOARD OF TRUSTEES
    • APPLY FOR NAAMA FOUNDATION GRANT
    • NAAMA FOUNDATION DISBURSED GRANTS
    • NAAMA FOUNDATION HISTORY ARCHIVE
    • NAAMA FOUNDATION RELIEF CAMPAIGNS
    • ACTIVE RELIEF CAMPAIGNS
  • CHAPTERS
    • NAAMA CHAPTERS
    • CHAPTERS’ NEWS
    • Start New Chapter
  • WOMEN IN NAAMA
    • WOMEN IN NAAMA-WIN
  • NEXTGEN
  • NEWS & PRESS RELEASE
    • NEWS LIST
    • NEWSLETTERS
    • PRESS RELEASE
    • MEMBERS NEWS
    • GALLERY
  • CONVENTIONS
    • CURRENT | UPCOMING
    • PAST CONVENTION
    • CONFLICT OF INTEREST DISCLOSURE
    • CME APPLICATION
  • EVENTS CALENDAR
    • UPCOMING | CURRENT EVENTS
    • PAST EVENTS
  • CME & Resources
  • GET INVOLVED
    • DONATE
    • MEMBERSHIP
    • VOLUNTEER
    • CAREER
logo main
DONATE
  • HOME
  • ABOUT
    • ABOUT
    • NAAMA PRESIDENT
      • NAAMA PRESIDENT
      • PRESIDENT’S LETTERS
        • PRESIDENT’S LETTERS 2025
        • PRESIDENT’S LETTERS 2024
        • PRESIDENT’S LETTERS 2023
    • GOVERNING BOARDS
      • BOARD OF DIRECTORS
      • EXECUTIVE COMMITTEE
    • COMMITTEES
      • NAAMA Committees
    • BYLAWS
  • FOUNDATION
    • BOARD OF TRUSTEES
    • APPLY FOR NAAMA FOUNDATION GRANT
    • NAAMA FOUNDATION DISBURSED GRANTS
    • NAAMA FOUNDATION HISTORY ARCHIVE
    • NAAMA FOUNDATION RELIEF CAMPAIGNS
    • ACTIVE RELIEF CAMPAIGNS
  • Membership
  • CHAPTERS
    • NAAMA CHAPTERS
    • CHAPTERS’ NEWS
    • Start New Chapter
  • NEXTGEN
  • NEWS & PRESS RELEASE
    • NEWS LIST
    • NEWSLETTERS
    • PRESS RELEASE
    • MEMBERS NEWS
    • GALLERY
  • CONVENTIONS
    • CURRENT | UPCOMING
    • PAST CONVENTION
    • CONFLICT OF INTEREST DISCLOSURE
    • CME APPLICATION
  • EVENTS CALENDAR
    • UPCOMING | CURRENT EVENTS
    • PAST EVENTS
    • WOMEN IN NAAMA-WIN
  • CME & Resources
  • ACTIVE CAMPAIGNS
  • GET INVOLVED
    • DONATE
    • VOLUNTEER
    • CAREER

Lisbon Convention Evaluation-Pathology Symposium


Transforming Patient Care

Bridging Innovation & Clinical Practice Across Borders

Lisbon, Portugal

July 3 – July 5, 2026

This activity is approved for 4.5 hours of category 1 CME, please enter number of hours claimed

Please enter your title the way you want it in the certificate
Please enter your full name the way you want it in the certificate

Section 1 refers to the entire course/activity:

Please indicate your level of agreement:

1. The course objectives were met. *
2. As a result of participating in this conference, I am confident I will improve my knowledge, and/or patient outcomes. *
3. As a result of participating in this activity, I am confident I will improve my competence in(specify activity area)
4. As a result of participating in this activity, I am confident I can improve my performance in *(specify activity area)
5. The content will be useful in my practice *
6. What areas of practice will you change as a result of attending this course?Select all that apply
7. The educational delivery method selected was effective
Type your comments.

Helder Oliveira Coelho, MD, Histopathology Beyond Morphology: Predictive Medicine in the Age of AI

July 4 - 9:10-9:40

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Paula Nunes, MD, PhD, Beyond the Basics: IBD for the Next Gen Pathologist

July 4 - 9:40-10:10

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Ibrahim Khalifeh, MD: Diagnosing Skin Appendageal Neoplasms: A Practical Approach for the Modern Pathologist

July 4 - 10:10-10:40

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Ricardo Fonseca, MD: Pancreatic Cystic Lesions: Cells, Challenges, and Clinical Impact

July 4 - 10:55-11:20

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Aleodor Andea, MD, PHD: Difficult Melanocytic Lesions: Avoiding Misdiagnosis and Missed Diagnosis

July 4 11:25-11:55

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Simona Stolnicu, MD, PhD: The role of HPV status in the classification and diagnosis of cervical epithelial malignant tumors and precursors

July 4 - 11:55-12:25

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Eyas Hattab, MD: Beyond Borders: Rebuilding the Diagnostic Workforce Through Global Talent and Training Reform

July 4 - 1:30-2:00

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)

Daniel Pinto, MD: State of the Art of Precision Medicine and Molecular Testing in Breast Cancer

July 4 - 2:00-2:30

Did you attend this session? *Did you attend this session?
This session met the objectives *This session met the objectives
Session was free of commercial bias *Session was free of commercial bias
This session was: (5=excellent, 1=poor)
Select number of CME credit hours claimed (MAX is 4.5 Credit only)

This activity is planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the National Arab American Medical Association (NAAMA). The National Arab American Medical Association is accredited by the ACCME to provide continuing medical education for physicians. NAAMA designates this educational activity for a maximum of 4.5 hours of category 1 CME Credits™. Physicians should claim only the credit commensurate with the extent of their participation.

None of the planners or speakers has a conflict of interest.

Start signing your signature here

Your browser does not support e-Signature field.

Save as Draft
NAAMA Volunteer Donation

Our info

+1(248) 646-3661
+1(248) 457-5036
naama@naama.com
2265 Livernois Rd Suite 720,
Troy, MI 48083, USA

Short Link

  • Donate
  • Active Campaigns

About us

NAAMA will promote the professional development and cultural identity of healthcare professionals with roots or affinity to the Arab World.

Copyright © 2025 National Arab American Medical Association. | Designed and maintained by ™ smartlinkselv.com

NAAMA!

NAAMA is proud to be an all-inclusive association that acts as the voice of all Arab American healthcare professionals and addresses their professional and cultural needs. Through educational, philanthropic and service activities, NAAMA will promote the professional development and cultural identity of healthcare professionals with roots or affinity to the Arab World! NAAMA is a licensed CME provider and a 501(c)3 nonprofit organization.

Our info

Phone +1(248) 646-3661

Email: naama@naama.com

Website: www.naama.com

2265 Livernois Rd. Suite 720,
Troy, MI 48083, USA

Follow us